BibTex RIS Cite

Etanercept protects remote organ damage in a rat model of thermal injury

Year 2011, Volume: 15 Issue: 3, 118 - 124, 07.03.2014

Abstract

References

  • Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns 2008;34:6-17.
  • Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 1993;121:328-36.
  • Kataranovski M, Magić Z, Pejnović N. Early inflammato- ry cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res 1999;48:473- 82.
  • Yamashita Y, Jeschke MG, Wolf SE. Differential expres- sion of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in rats. Cytokine 2000;12:1293-8.
  • Meakins JL. Etiology of multiple organ failure. J Trauma 1990;30:S165–8.
  • Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998;10:79–89).
  • Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KA, Banerjee A, et al. Tumor necrosis factor-a and inter- leukin-1b synergistically depress human myocardial function. Crit Care Med 1999;27: 1309-18.
  • Giroir B, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994; 267: H118-24.
  • Taylor PC. Pharmacology of TNF blockade in rheuma- toid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol 2010;10:308-15.
  • Goldenberg MM. Etanercept, a novel drug for the treat- ment of patients with severe, active rheumatoid arthritis. Clin Ther 1999;21:75-87.
  • Martinek RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 1972;40:91–9.
  • Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–11.
  • B eutler E. Glutathione. In: Red blood cell metabolism. A Manuel of Biochemical Methods, Grune and Stratton, New York, NY.1975:112–14.
  • Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Der- matol 1982;78:206-9.
  • Hillega ss LM, Griswold DE, Brickson B, Albrightson- Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285-95.
  • K im YK, Lee SH, Goldinger JM, Hong SK. Effect of eth- anol on organic ion transport in rabbit kidney. Toxicol Appl Pharmacol 1986;86:411-20.
  • Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol Cogn Med Sci 1980;65:105-16.
  • F iske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375–400.
  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Pro- tein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
  • Teodorczyk-Injeyan J A, Sparkes B G, Mills G B, Peters W J, Falk R E. Impairment of T cell activation in burn pa- tients: a possible mechanism of thermal injury induced immunosuppression. Clin Exp Immunol 1986;65:570-81.
  • Pruitt B A. Jr. Infection and the burn patient. Br JSurg 1990;77, 1081-2.
  • O’Sullivan ST, O’Connor T P Immunosuppression fol- lowing thermal injury: the pathogenesis of immunodys- function. Br J Plast Surg 1997; 50: 615-23.
  • Horton JW. Free radicals and lipid peroxidation mediat- ed injury in burn trauma: the role of antioxidant therapy. Toxicology 2003;189:75–88.
  • Ravage ZB, Gomez HF, Czermak BJ, Watkins SA, Till GO. Mediators of microvascular injury in dermal burn wounds. Inflammation 1998;22:619-29.
  • Yeh FL, Lin WL, Shen HD. Changes in circulating lev- els of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 2000;26:454-9.
  • Wang G, Tian J, Tang H, Zhu S, Huan J, Ge S, Xia Z. (The role of Kupffer cells on the postburn production of TN- Falpha, IL-1beta and IL-6 in severely scalded rats). Zhon- ghua Shao Shang Za Zhi. 2002;18:282-4.
  • Toklu HZ, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, Sener, G. Silymarin, the antioxidant component of Si- lybum marianum, protects against burn induced oxida- tive skin injury. Burns 2007;33:908-16.
  • Reiter RJ , Tan DX, Manchester LC, Qi W. Biochemical re- activity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys 2001;34:237-56.
  • Yilmaz M, Topsakal S, Herek O, Ozmen O, Sahinduran S, Buyukoglu T, et al. Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats. Transl Res 2009;154:241-9.
  • Genovese T, Mazzon E, Crisafulli C, Esposito E, Di Paola R, Muià C, et al. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007;150:168-81.
  • Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC. Inhibition of TNF-alpha reduces myocar- dial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol 2006;48:320-8.
  • Sabry A, Wafa I, El-Din AB, El-Hadidy AM, Hassan M. Early markers of renal injury in predicting outcome in thermal burn patients. Saudi J Kidney Dis Transpl 2009;20:632-8.
  • Pintaudi AM, Tesoriere L, D’Arpa N, D’Amelio L, D’Arpa D, Bongiorno A, et al. Oxidative stress after moderate to extensive burning in humans. Free Radic Res. 2000;33:139-46.
  • Sener G, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yeğen BC. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 2005;31:587-96.
  • Sener G, Sehirli AO, Gedik N, Dülger GA. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns 2007;33:587-93.
  • Koksel O, Ozdulger A, Tamer L, Cinel L, Ercil M, De- girmenci U, et al. Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats. Pulm Pharmacol Ther 2006;19:90-5.
  • Koksel O, Kaplan MB, Ozdulger A, Tamer L, Degirmenci U, Cinel L, et al. Oleic acid-induced lung injury in rats and effects of caffeic acid phenethyl ester. Exp Lung Res 2005;31:483-96.
  • Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L, Araya J. Changes in (Na + K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxica- tion. Chest 2002;121:589-96.
  • Furst DE. Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis. Clin Exp Rheuma- tol 2010;28(3 Suppl 59):S5-12.
  • Di Paola R, Mazzon E, Muià C, Crisafulli C, Terrana D, Greco S, et al. Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol 2007;150:286-97.

of Pharmacy, Istanbul, Türkiye

Year 2011, Volume: 15 Issue: 3, 118 - 124, 07.03.2014

Abstract

References

  • Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns 2008;34:6-17.
  • Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 1993;121:328-36.
  • Kataranovski M, Magić Z, Pejnović N. Early inflammato- ry cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res 1999;48:473- 82.
  • Yamashita Y, Jeschke MG, Wolf SE. Differential expres- sion of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in rats. Cytokine 2000;12:1293-8.
  • Meakins JL. Etiology of multiple organ failure. J Trauma 1990;30:S165–8.
  • Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998;10:79–89).
  • Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KA, Banerjee A, et al. Tumor necrosis factor-a and inter- leukin-1b synergistically depress human myocardial function. Crit Care Med 1999;27: 1309-18.
  • Giroir B, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994; 267: H118-24.
  • Taylor PC. Pharmacology of TNF blockade in rheuma- toid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol 2010;10:308-15.
  • Goldenberg MM. Etanercept, a novel drug for the treat- ment of patients with severe, active rheumatoid arthritis. Clin Ther 1999;21:75-87.
  • Martinek RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 1972;40:91–9.
  • Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–11.
  • B eutler E. Glutathione. In: Red blood cell metabolism. A Manuel of Biochemical Methods, Grune and Stratton, New York, NY.1975:112–14.
  • Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Der- matol 1982;78:206-9.
  • Hillega ss LM, Griswold DE, Brickson B, Albrightson- Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285-95.
  • K im YK, Lee SH, Goldinger JM, Hong SK. Effect of eth- anol on organic ion transport in rabbit kidney. Toxicol Appl Pharmacol 1986;86:411-20.
  • Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol Cogn Med Sci 1980;65:105-16.
  • F iske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375–400.
  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Pro- tein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
  • Teodorczyk-Injeyan J A, Sparkes B G, Mills G B, Peters W J, Falk R E. Impairment of T cell activation in burn pa- tients: a possible mechanism of thermal injury induced immunosuppression. Clin Exp Immunol 1986;65:570-81.
  • Pruitt B A. Jr. Infection and the burn patient. Br JSurg 1990;77, 1081-2.
  • O’Sullivan ST, O’Connor T P Immunosuppression fol- lowing thermal injury: the pathogenesis of immunodys- function. Br J Plast Surg 1997; 50: 615-23.
  • Horton JW. Free radicals and lipid peroxidation mediat- ed injury in burn trauma: the role of antioxidant therapy. Toxicology 2003;189:75–88.
  • Ravage ZB, Gomez HF, Czermak BJ, Watkins SA, Till GO. Mediators of microvascular injury in dermal burn wounds. Inflammation 1998;22:619-29.
  • Yeh FL, Lin WL, Shen HD. Changes in circulating lev- els of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 2000;26:454-9.
  • Wang G, Tian J, Tang H, Zhu S, Huan J, Ge S, Xia Z. (The role of Kupffer cells on the postburn production of TN- Falpha, IL-1beta and IL-6 in severely scalded rats). Zhon- ghua Shao Shang Za Zhi. 2002;18:282-4.
  • Toklu HZ, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, Sener, G. Silymarin, the antioxidant component of Si- lybum marianum, protects against burn induced oxida- tive skin injury. Burns 2007;33:908-16.
  • Reiter RJ , Tan DX, Manchester LC, Qi W. Biochemical re- activity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys 2001;34:237-56.
  • Yilmaz M, Topsakal S, Herek O, Ozmen O, Sahinduran S, Buyukoglu T, et al. Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats. Transl Res 2009;154:241-9.
  • Genovese T, Mazzon E, Crisafulli C, Esposito E, Di Paola R, Muià C, et al. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007;150:168-81.
  • Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC. Inhibition of TNF-alpha reduces myocar- dial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol 2006;48:320-8.
  • Sabry A, Wafa I, El-Din AB, El-Hadidy AM, Hassan M. Early markers of renal injury in predicting outcome in thermal burn patients. Saudi J Kidney Dis Transpl 2009;20:632-8.
  • Pintaudi AM, Tesoriere L, D’Arpa N, D’Amelio L, D’Arpa D, Bongiorno A, et al. Oxidative stress after moderate to extensive burning in humans. Free Radic Res. 2000;33:139-46.
  • Sener G, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yeğen BC. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 2005;31:587-96.
  • Sener G, Sehirli AO, Gedik N, Dülger GA. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns 2007;33:587-93.
  • Koksel O, Ozdulger A, Tamer L, Cinel L, Ercil M, De- girmenci U, et al. Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats. Pulm Pharmacol Ther 2006;19:90-5.
  • Koksel O, Kaplan MB, Ozdulger A, Tamer L, Degirmenci U, Cinel L, et al. Oleic acid-induced lung injury in rats and effects of caffeic acid phenethyl ester. Exp Lung Res 2005;31:483-96.
  • Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L, Araya J. Changes in (Na + K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxica- tion. Chest 2002;121:589-96.
  • Furst DE. Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis. Clin Exp Rheuma- tol 2010;28(3 Suppl 59):S5-12.
  • Di Paola R, Mazzon E, Muià C, Crisafulli C, Terrana D, Greco S, et al. Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol 2007;150:286-97.
There are 40 citations in total.

Details

Primary Language English
Journal Section Articles
Authors

Ahmet Şehirli This is me

Burcu Ünlü This is me

Şule Çetinel This is me

Şermin Tetik

Emre Şener This is me

Göksel Şener

Publication Date March 7, 2014
Published in Issue Year 2011 Volume: 15 Issue: 3

Cite

APA Şehirli, A., Ünlü, B., Çetinel, Ş., Tetik, Ş., et al. (2014). Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharmaceutical Journal, 15(3), 118-124. https://doi.org/10.12991/mpj.14363
AMA Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G. Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharm J. March 2014;15(3):118-124. doi:10.12991/mpj.14363
Chicago Şehirli, Ahmet, Burcu Ünlü, Şule Çetinel, Şermin Tetik, Emre Şener, and Göksel Şener. “Etanercept Protects Remote Organ Damage in a Rat Model of Thermal Injury”. Marmara Pharmaceutical Journal 15, no. 3 (March 2014): 118-24. https://doi.org/10.12991/mpj.14363.
EndNote Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G (March 1, 2014) Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharmaceutical Journal 15 3 118–124.
IEEE A. Şehirli, B. Ünlü, Ş. Çetinel, Ş. Tetik, E. Şener, and G. Şener, “Etanercept protects remote organ damage in a rat model of thermal injury”, Marmara Pharm J, vol. 15, no. 3, pp. 118–124, 2014, doi: 10.12991/mpj.14363.
ISNAD Şehirli, Ahmet et al. “Etanercept Protects Remote Organ Damage in a Rat Model of Thermal Injury”. Marmara Pharmaceutical Journal 15/3 (March 2014), 118-124. https://doi.org/10.12991/mpj.14363.
JAMA Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G. Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharm J. 2014;15:118–124.
MLA Şehirli, Ahmet et al. “Etanercept Protects Remote Organ Damage in a Rat Model of Thermal Injury”. Marmara Pharmaceutical Journal, vol. 15, no. 3, 2014, pp. 118-24, doi:10.12991/mpj.14363.
Vancouver Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G. Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharm J. 2014;15(3):118-24.